U.S. Treasury Proposes Outbound-Investment Curbs on China's Biotech Sector

The U.S. Treasury Department proposed on Oct. 22, 2026, to add biotechnology to the list of sensitive technologies covered by outbound-investment controls targeting China and other 'countries of concern.' The draft rule, which is not yet in effect, combines outright prohibitions with mandatory notification requirements and excludes licensing agreements.